Acera’s mission is to set a new standard of excellence in healthcare. We take seriously the trust placed in us by patients and clinicians alike. Our team of pioneers, change agents, innovators, and scientists are bound together by an unrelenting drive to create solutions that make patients’ lives better through the development of revolutionary products that enable healing and enhance quality of life.
A Message to our Customers and Stakeholders:
Acera Surgical takes the health and well-being of our employees, as well as the patients and customers we serve, very seriously. During this COVID-19 crisis, we have taken the necessary safety measures established by the CDC to help protect our employees and their families. At the same time, we remain committed to meeting the needs of our customers and patients.
Our lead product, Restrata, is indicated for use in the management of wounds, including surgical and trauma wounds, along with pressure, diabetic, venous, and chronic vascular ulcers1. Other solutions for soft-tissue repair present tradeoffs, either for patients or providers. Autografts require a second procedure to harvest skin from a patient, leading to increased OR time and patient discomfort; many allografts require tissue tracking and special storage requirements; while most xenografts include biologic components derived from animal tissue that could present a risk of disease transmission to the patient2.
How we can help:
- We manufacture our non-biologic, fully synthetic products in the U.S.A.
- Unlike human or animal based tissue products, Restrata eliminates the risk of disease transmission associated with harvested tissues2
- Restrata is terminally sterilized with a two-year shelf-life, and does not require any special tissue tracking or storage requirements
- We have a strong supply-chain and sufficient inventory on hand to help providers and patients
Acera Surgical remains available to support you during this time. Please do not hesitate to contact our Customer Service team (844-879-2237) or your local Surgical Account Executive with any questions or concerns.
1Please refer to the Restrata package insert for cleared indications and instructions for use.
2MacEwan MR, MacEwan S, Kovacs TR, et al. (October 2, 2017) What Makes the Optimal Wound Healing Material? A Review of Current Science and Introduction of a Synthetic Nanofabricated Wound Care Scaffold. Cureus Journal of Medical Science 9(10): e1736. doi:10.7759/cureus.1736